CFDE Data Portal | Search CISD3

	Label	Description
	CISD3 Gene (Entity type)	ENSG00000277972 - CDGSH iron sulfur domain 3
	CISD3 associations Collection (Entity type)	Associations for CISD3_associations
	CISD3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CISD3 Gene (Entity type)	ENSG00000274768 - CDGSH iron sulfur domain 3 [Source:HGNC Symbol;Acc:HGNC:27578]
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158632 3 V 5 OXYQUINOLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS

CISD3

ENSG00000277972 - CDGSH iron sulfur domain 3

CISD3 associations

Associations for CISD3_associations

CISD3 associations.tsv

A file from IDG as part of the Harmonizome project

CISD3

ENSG00000274768 - CDGSH iron sulfur domain 3 [Source:HGNC Symbol;Acc:HGNC:27578]

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE158632 3 V 5 OXYQUINOLINE HUMAN DN

A Gene Set from LINCS

GSE261563 CX-5461 6 v 1 human up

A Gene Set from LINCS

GSE195663 cisplatin 0 v 3 human up

A Gene Set from LINCS

GSE216043 cisplatin 7 v 0 human dn

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 8 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.